Alerts
CDMO Cell Therapies
December 15, 2019
At the end of 2014, a new production area was initially established for an owned Cell Therapy Process.
The facilities were also designed to offer the development and GMP manufacturing of Autologous or Allogeneic cell therapy and tissue engineered products for third parties.
